VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation.
Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation. Blood. 2013 Jun 06; 121(23):4655-62.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Azacitidine
Feasibility Studies
Female
fms-Like Tyrosine Kinase 3
Follow-Up Studies
Humans
Leukemia, Myeloid, Acute
Male
Middle Aged
Mutation
Neoplasm Recurrence, Local
Niacinamide
Phenylurea Compounds
Prognosis
Remission Induction
Survival Rate
Tandem Repeat Sequences
Young Adult
authors with profiles
MICHAEL ANDREEFF
HAGOP M KANTARJIAN
JORGE E CORTES
MARINA KONOPLEVA
FARHAD RAVANDI-KASHANI
GUILLERMO GARCIA-MANERO
GAUTAM BORTHAKUR
TAPAN MAHENDRA KADIA
JAN ANDREAS BURGER
NAVAL DAVER